blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4204049

EP4204049 - INHALER AND METHOD AND ARRANGEMENT FOR ADMINISTERING AN ACTIVE SUBSTANCE [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  02.06.2023
Database last updated on 18.10.2024
FormerThe international publication has been made
Status updated on  05.03.2022
Formerunknown
Status updated on  24.09.2021
Most recent event   Tooltip22.08.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
Körber Technologies GmbH
Kurt-A.-Körber-Chaussee 8-32
21033 Hamburg / DE
[2023/27]
Inventor(s)01 / HANNEKEN, Christian
22299 Hamburg / DE
02 / CAPONE, Michael Joseph
22087 Hamburg / DE
 [2023/27]
Representative(s)Stork Bamberger Patentanwälte PartmbB
Meiendorfer Strasse 89
22145 Hamburg / DE
[2023/27]
Application number, filing date21769926.325.08.2021
[2023/27]
WO2021EP73512
Priority number, dateDE20201012265131.08.2020         Original published format: DE102020122651
[2023/27]
Filing languageDE
Procedural languageDE
PublicationType: A1 Application with search report
No.:WO2022043380
Date:03.03.2022
Language:DE
[2022/09]
Type: A1 Application with search report 
No.:EP4204049
Date:05.07.2023
Language:DE
The application published by WIPO in one of the EPO official languages on 03.03.2022 takes the place of the publication of the European patent application.
[2023/27]
Search report(s)International search report - published on:EP03.03.2022
ClassificationIPC:A61M15/00, G01N27/22, A61M15/06, A61M11/02, A24F40/50, A61M16/00, A61M11/00
[2023/27]
CPC:
A61M15/009 (EP); A61M15/0066 (US); A24F40/53 (EP);
A61M11/005 (EP,US); A61M11/02 (EP); A61M11/045 (US);
A61M15/0085 (EP,US); A61M15/06 (EP); A61M16/0003 (US);
A24F40/05 (EP); A24F40/10 (EP); A61M11/042 (EP);
A61M2016/0018 (EP,US); A61M2016/0027 (EP); A61M2016/0033 (EP,US);
A61M2205/276 (US); A61M2205/332 (EP); A61M2205/3334 (EP);
A61M2205/3358 (EP); A61M2205/3379 (EP); A61M2205/3553 (EP);
A61M2205/3561 (EP,US); A61M2205/3569 (EP); A61M2205/3584 (EP);
A61M2205/3592 (EP); A61M2205/50 (EP); A61M2205/8206 (EP);
A61M2230/06 (EP); A61M2230/201 (EP); A61M2230/30 (EP);
G01F1/34 (EP); G01F1/69 (EP); G01F1/88 (EP) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2023/27]
TitleGerman:INHALATOR SOWIE VERFAHREN UND ANORDNUNG ZUM VERABREICHEN EINES WIRKSTOFFS[2023/27]
English:INHALER AND METHOD AND ARRANGEMENT FOR ADMINISTERING AN ACTIVE SUBSTANCE[2023/27]
French:INHALATEUR ET PROCÉDÉ ET AGENCEMENT D'ADMINISTRATION D'UN PRINCIPE ACTIF[2023/27]
Entry into regional phase24.03.2023National basic fee paid 
24.03.2023Designation fee(s) paid 
24.03.2023Examination fee paid 
Examination procedure24.03.2023Examination requested  [2023/27]
24.03.2023Date on which the examining division has become responsible
26.09.2023Amendment by applicant (claims and/or description)
Fees paidRenewal fee
23.08.2023Renewal fee patent year 03
22.08.2024Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]US5284133  (BURNS JAMES S [US], et al) [X] 1-11 * figures 2-5 * * column 8, line 1 - column 11, line 10 *;
 [X]WO2018107018  (MICRODOSE THERAPEUTX INC [US]) [X] 1-11,21 * figures 1-6 ** paragraph [0021] - paragraph [0051] *;
 [X]WO2018175579  (MICRODOSE THERAPEUTX INC [US]) [X] 1-11 * figures 1-13 * * paragraph [0026] - paragraph [0049] *;
 [X]US2019240430  (JACKSON DAVID N [US], et al) [X] 1-11,21 * figures 1-17 * * paragraph [0048] - paragraph [0095] *;
 [X]WO2019239217  (NEXVAP SA [CH]) [X] 1-11 * figures 1-24 * * paragraph [0116] - paragraph [0122] *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.